Immunological alterations with GLP-1 agonists in people living with HIV

HIV Med. 2024 Jul;25(7):893-894. doi: 10.1111/hiv.13631. Epub 2024 Mar 3.

Authors

Sebastian Noe¹, Anna Ivanova², Celia Johnsson-Oldenbüttel¹, Guido Schäfer³, Knud Schewe³, Christian Hoffmann^{3

4}

Affiliations

¹ MVZ München am Goetheplatz, Munich, Germany.
² UHasselt, Data Science Institute, Hassel, Belgium.
³ ICH Study Center, Hamburg, Germany.
⁴ University Hospital of Schleswig Holstein, Campus Kiel, Germany.

PMID: 38433467
DOI: 10.1111/hiv.13631

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Female
Glucagon-Like Peptide 1* / agonists
HIV Infections* / drug therapy
HIV Infections* / immunology
Humans
Male
Middle Aged

Substances

Glucagon-Like Peptide 1